Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosilate vs Propofol for Sedation in Painless Gastrointestinal Endoscopy
ChiCTR2100050797Phase 4Recruiting
- Sponsor
- Nanning Second People's Hospital
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Nanning Second People's Hospital. Primary endpoints: blood pressure, heart rate and 2 more. Started Jul 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100050797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050797.